Intraregional repeated injections of living or killed Bifidobacterium infantis i nhibited the growth of established Meth-A tumor cells transplanted subcutaneousl y into syngeneic BALB/c mice (regression) . When tumor cells mixed with B infantis were inoculated subcutaneously into mice , tumors did not develop in the majority of the recipient mice (suppression) . Water-insoluble cell walls which were obtained b y sonication of kill ed B. infantis induced suppression of tumor development but failed to induce regression of tumor growth when these preparations were injected intraregionally after tumor implantation . In contrast, although the water-soluble supernatant fractions of sonicated killed B . infantis did not exhibit tumor suppression , ef-f ective regression of established tumors followed intraregional injection of these fractions. The immunological adjuvant effects of B . infantis or its components were also studied. These bacterial preparations potentiated both tumor tra nsplantation i mmunity and the delayed-type hypersensitivity response against sheep erythrocytes in mice.
It has been demonstrated that certain bacteria such as BCG (14 , 15) , Corynebacterium (2, 4) , and Streptococcus haemolyticus (5, 11) , are effective in preventing tumor growth in experimental animals. These bacteria are also used clinically for experimental tumor immunotherapy , as they stimulate host immune functions in immunologically non-specific ways . The administration of living bacteria to cancer patients or to animals has sometimes caused systemic bacterial infection and toxicity . To avoid toxicity, preparations of nonliving bacteria or their components (1 , 3) have been tested in the immunotherapy of cancer. In this respect, it is of interest to see whether non-pathogenic bacteria show antitumor effects like those of the already known antitumor bacteria .
From this viewpoint, we examined the antitumor effect of Bifidobacterium infantis (5) , which is a Gram-positive anaerobic bacterium isolated from the feces of human infants (7) , and its components against a murine sarcoma transplanted into syngeneic animals (in preparation) . We also examined the immunological adjuvant effects of B . infantis and its components (in preparation) . 1 (8) , and washed and suspended in PBS. Nonliving bacterial preparations were obtained by keeping the living bacteria under aerobic conditions for 3 to 7 days, and were certified for loss of growth ability.
A lyophilized preparation of penicillintreated S. haemolyticus (12) was donated by Chugai Pharmaceutical Co., Tokyo. One KE (clinical unit) of this preparation corresponds to 0.1 mg (108 cells) of dry bacteria.
Preparation of water-insoluble cell walls and water-soluble supernatant fraction: The lyophilized B. infantis were suspended in PBS for 40 mg/m1 and were broken up in a Branson cell disruptor for 30 min in icecold conditions. The homogenate was centrifuged at 2000 rpm for 10 min and the pellet of complete bacterial cells was discarded. Cell wall and supernatant fractions were treated as detailed in Fig. 2 . All preparations were dialized against distilled water and lyophilized.
Test of antitumor effect of microorganisms: A volume of 0.1 ml of a suspension containing a known number of Meth-A cells was inoculated intraperitoneally or subcutaneously into BALB/c mice, with or without bacteria.
In the latter case, the mice were repeatedly injected with bacteria at the tumor-inoculated site. Table 3 . Effect of intraperitoneal injection of bacteria on intraperitoneally inoculated Meth-A tumor cells Antitumor activity in vivo of sonicated bacterial fraction: A mixture of various fractions and Meth-A tumor cells was inoculated subcutaneously into the right flank of BALB/c mice. Tumor growth was inhibited by B. infantis or the cell wall fraction, but water-soluble supernatant fractions were all ineffective in inhibiting Meth-A tumor growth. On the other hand, BALB/c mice inoculated with Meth-A tumor cells subcutaneously had tumors established 5 days thereafter, cell wall or water-soluble supernatant fractions then being injected into the same site of the inoculated tumor cells at a dose of 0.1 mg/injection on days 5 to 12 8 times. Cell wall of B. infantis was ineffective for tumor regression, but water- 
Discussion
Two strains of Bifidobacterium isolated from a human exhibited a remarkable antitumor effect against Meth-A sarcoma cells transplanted into syngeneic BALB/c mice . Referring to the antitumor mechanisms presented for other bacteria, several possibilities can be considered: (1) Bacteria are cytotoxic to tumor cells, (2) inflammatory response may develop against the bacteria and tumor cells present in such a locus could be damaged nonspecifically as `innocent bystanders,' (3) injection of bacteria may produce an augmentation of host immune response specific to the tumor , or (4) a combination of the above mechanisms. The first possibility can be ruled out from the fact that bifidobacteria are not cytotoxic to tumor cells in vitro (unpublished data) . The second one is likely since tumor cells inoculated with the bacteria were suppressed in their growth, suggesting the role of an acute and local host-mediated reaction. However, in the therapeutic model , where the treatment with bacteria was undertaken the day after tumor inoculation, tumors grew for 1 week and then regressed. This finding may suggest the involvement of a host-mediated immunological response to tumor, at least to some extent, together with the nonspecific local reaction. This assumption could be substantiated from the finding that the mice that survived this experiment rejected the rechallenged tumor cells, indicating the acquirement of transplantation immunity to Meth-A cells. Furthermore, surviving mice which had been inoculated with tumor cells mixed with bacteria accepted rechallenge of the tumor cells and died , probably due to insufficient antigenic stimulation with the first reaction . Taken together, destruction of a part of the tumor cells by the bacteria and the following immunological stimulation with the tumor may account for the antitumor mechanism of the bacteria. Like C. parvum and P . acnes, killed Bifidobacterium was as effective as living, indicating the viability or growth of bacteria in the recipient animals could not be a predominant factor for the antitumor effect.
Further study on the augumentation of immunological function in the host stimulated with B. infantis and the isolation and analysis of the effective component of B . infantis is considered to be important , since BCG cell-wall (13) has been shown to be as effective as and less toxic than the original bacteria.
